Idelvion Approved for Hemophilia B

MONDAY, March 7, 2016 -- Idelvion has been approved by the U.S. Food and Drug Administration to replace a deficient blood clotting factor among people with hemophilia B. The product -- which has the generic name of "coagulation Factor IX, albumin...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news